Cargando…
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers
Treatments targeting the Ebola virus may eventually be shown to work, but they will not have an impact on overall Ebola mortality in West Africa. Endothelial dysfunction is responsible for the fluid and electrolyte imbalances seen in Ebola patients. Because inexpensive generic statins and angiotensi...
Autores principales: | Fedson, David S., Jacobson, Jeffrey R., Rordam, Ole Martin, Opal, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479704/ https://www.ncbi.nlm.nih.gov/pubmed/26106080 http://dx.doi.org/10.1128/mBio.00716-15 |
Ejemplares similares
-
Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
por: Fedson, David S., et al.
Publicado: (2016) -
Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Wiwanitkit, Viroj
Publicado: (2016) -
Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: Fedson, David S., et al.
Publicado: (2020) -
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19
Infection
por: Fedson, David S., et al.
Publicado: (2020) -
Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)